Techniques in Vascular & Interventional Radiology
Volume 9, Issue 3 , Pages 106-112 , September 2006

Postprocedure Clinical Management for the Interventional Radiologist

  • Katherine Thornton, MD

      Affiliations

    • Corresponding Author InformationAddress reprint requests to Department of Medical Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins Medical Institutions, 1650 Orleans Street CRB I, Room 187, Baltimore, MD 21231.

References 

  1. Lanigan D, Jurriaans E, Hammonds JC, et al. The current status of embolization in renal cell carcinoma: A survey of local and national practice. Clin Radiol. 1992;46:176–178
  2. Chuang VP, Wallace S, Soo CS, et al. Therapeutic ivalon embolization of hepatic tumors. AJR Am J Roentgenol. 1982;138:289–294
  3. Siskin GP, Bonn J, Worthington-Kirsch RL, et al. III. uterine fibroid embolization: Pain management. Tech Vasc Interv Radiol. 2002;5:35–43
  4. Cherny NI, Portenoy RK. The management of cancer pain. CA Cancer J Clin. 1994;44:263–303
  5. Grossman SA, Dunbar EM, Nesbit SA. Cancer pain management in the 21st century. Oncology (Williston Park). 2006;20:1333–1339discussion 1340-1342, 1347-1348, 1351
  6. Roth AR, Spies JB, Walsh SM, et al. Pain after uterine artery embolization for leiomyomata: Can its severity be predicted and does severity predict outcome?. J Vasc Interv Radiol. 2000;11:1047–1052
  7. Sohara N, Takagi H, Abe T, et al. Nausea and vomiting induced by arterial chemo-embolization in patients with hepatocellular carcinoma and the antiemetic effect of ondansetron hydrochloride. Support Care Cancer. 1999;7:84–88
  8. National Comprehensive Cancer Network. Practice Guidelines in Oncology Version 1. 2007;Emetogenic Potential of Antineoplastic Drugs http://www.nccn.org/professionals/physician_gls/PDF/antiemesis.pdf. Accessed February 19, 2007
  9. Kim W, Clark TW, Baum RA, et al. Risk factors for liver abscess formation after hepatic chemoembolization. J Vasc Interv Radiol. 2001;12:965–968
  10. Chen C, Chen PJ, Yang PM, et al. Clinical and microbiological features of liver abscess after transarterial embolization for hepatocellular carcinoma. Am J Gastroenterol. 1997;92:2257–2259
  11. Shun SC, Lai YH, Jing TT, et al. Fatigue patterns and correlates in male liver cancer patients receiving transcatheter hepatic arterial chemoembolization. Support Care Cancer. 2005;13:311–317
  12. National Comprehensive Cancer Network. Practice Guidelines in Oncology, v. 1. 2007;Myeloid Growth Factors in Cancer Treatment http://www.nccn.org/professionals/physician_gls/PDF/myeloid_growth.pdf. Accessed February 19, 2007
  13. Furukawa H, Hara T, Hoshino K, et al. An application of recombinant human granulocyte colony-stimulating factor (rhG-CSF) in a case of hepatocellular carcinoma combined with liver cirrhosis in which leukopenia developed after chemoembolization. Gastroenterol Jpn. 1991;26:779–782
  14. Bucaneve G, Micozzi A, Menichetti F, et al. Levofloxacin to prevent bacterial infection in patients with cancer and neutropenia. N Engl J Med. 2005;353:977–987
  15. Cullen M, Steven N, Billingham L, et al. Antibacterial prophylaxis after chemotherapy for solid tumors and lymphomas. N Engl J Med. 2005;353:988–998
  16. Hughes WT, Armstrong D, Bodey GP, et al. 2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer. Clin Infect Dis. 2002;34:730–751
  17. Sharma D, Ren Z, Xia J, et al. Acute tumor lysis syndrome after transcatheter arterial chemoembolization in a patient with hepatocellular carcinoma. Euro J Radiol Extra. 2006;58:49–51
  18. Gemici C. Tumour lysis syndrome in solid tumours. Clin Oncol. 2006;18:773–780[Royal College of Radiologists (Great Britain)]
  19. Cairo MS, Bishop M. Tumour lysis syndrome: New therapeutic strategies and classification. Br J Haematol. 2004;127:3–11
  20. Yarpuzlu AA. A review of clinical and laboratory findings and treatment of tumor lysis syndrome. Clin Chim Acta. 2003;333:13–18
  21. Pannu N, Wiebe N, Tonelli M. Alberta Kidney Disease Network: Prophylaxis strategies for contrast-induced nephropathy. JAMA. 2006;295:2765–2779
  22. Asif A, Epstein M. Prevention of radiocontrast-induced nephropathy. Am J Kidney Dis. 2004;44:12–24
  23. Becker CR, Davidson C, Lameire N, et al. High-risk situations and procedures. Am J Cardiol. 2006;98:37K–41K
  24. Huo TI, Wu JC, Lee SD. Contrast medium-associated renal dysfunction in patients with cirrhosis. Hepatology. 2004;40:1474;author reply 1474-1475
  25. Yamazaki H, Oi H, Matshushita M, et al. Renal cortical retention of contrast medium on delayed CT and nephropathy following transcatheter arterial chemoembolisation in patients with high serum creatinine level. Br J Radiol. 2002;75:874–878
  26. Jang JW, Choi JY, Bae SH, et al. A randomized controlled study of preemptive lamivudine in patients receiving transarterial chemo-lipiodolization. Hepatology. 2006;43:233–240
  27. Lau GK, Lie A, Liang R. Prophylactic lamivudine therapy for hepatitis B patients undergoing immunosuppressive therapy. Blood. 2002;100:3054
  28. Zhong S, Yeo W, Schroder C, et al. High hepatitis B virus (HBV) DNA viral load is an important risk factor for HBV reactivation in breast cancer patients undergoing cytotoxic chemotherapy. J Viral Hepat. 2004;11:55–59
  29. Kulke MH, Mayer RJ. Carcinoid tumors. N Engl J Med. 1999;340:858–868
  30. Roizen MF. Anesthetic implications of concurrent diseases. In:  Miller RD editors. Anesthesia. 5th ed.. Philadelphia: Churchill Livingstone; 2000;p. 982–984
  31. Veall GR, Peacock JE, Bax ND, et al. Review of the anaesthetic management of 21 patients undergoing laparotomy for carcinoid syndrome. Br J Anaesth. 1994;72:335–341
  32. Townsend CM, Sabiston DC. Sabiston Textbook of Surgery: The Biological Basis of Modern Surgical Practice. 17th ed.. Philadelphia: Saunders; 2004;
  33. Ahlman H, Ahlund L, Dahlstrom A, et al. SMS 201-995 and provocation tests in preparation of patients with carcinoids for surgery or hepatic arterial embolization. Anesth Analg. 1988;67:1142–1148

PII: S1089-2516(07)00002-9

doi: 10.1053/j.tvir.2007.01.001

Techniques in Vascular & Interventional Radiology
Volume 9, Issue 3 , Pages 106-112 , September 2006

Article Tools

* Image Usage & Resolution